Latest Talk
Update on the CRISPR IP Saga
Dr Claire Irvine (HGF), Douglas Drysdale (HGF), Tom Phillips (WIPR)
2020 has started with important European Patent Office decisions affecting the foundational CRISPR IP of both The Broad Institute and the University of California(UC) - firstly upholding of revocation of Broad's lead EP by an Appeal Board as a result of a highly publicised formal priority issue quickly followed by maintenance of UC's lead EP…
On-demand Talks
Related topics: